Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

FDA grants priority review for new brain cancer imaging agent

Pixclara (18F-FET) is a positron emission tomography product for the characterization of progressive or recurrent gliomas. 

phenylephrine FDA

FDA approves first RSV vaccine for adults

Pfizer's Abrysvo vaccine can now be prescribed to all adults 18 and older at high risk for severe RSV complications, including pregnant women. 

Chicago - Circa May 2018: Blue Cross Blue Shield headquarters signage and logo.

Blue Cross Blue Shield of New York sued over ‘ghost networks’

Thousands of patients have filed a class-action lawsuit against the insurer for issuing directories of providers who were out-of-network and did not take BCBS health plans. 

Code AI artificial intelligence

Industry Watcher’s Digest

Ransomware attacks even hurt hospitals that aren’t hit. 

Price shopping transparency

Radiology experts warn of unintended consequences stemming from imaging price transparency efforts

Researchers are expressing concern that this information may be motivating some to shy away from undergoing scheduled exams. 

artificial intelligence partnership on AI global cooperation

Partnership on AI valiantly trying to wrap arms around the world

It’s going to take a multinational effort for the global AI community—such as it is—to avoid the emergence of a “fragmented AI landscape.” 

heart doctors and surgeons working together. top cardiology hospitals in the United States.

Cardiothoracic surgeons unite to improve clinical practice guidelines

Four leading cardiothoracic surgery societies have joined forces in the name of developing clinical practice guidelines that are more thorough and consistent.

Thumbnail

Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more.